ASX erases losses as inflation at 4.6pc cools rate rise bets

March annual inflation slowed to 4.6% from a 4.8% forecast, but it remains well above the RBA’s target midpoint and keeps a third straight rate hike next week in play; traders now price a 76% chance versus 88% earlier. The ASX 200 fell 0.2% to 8691.20, with seven straight losses possible, while bond yields eased and the Australian dollar dipped to US71.71¢. On the stock side, Codan rose 16.4% after lifting FY guidance, OOh!media surged 40.6% on a $754 million takeover offer, and G8 Education plunged 22.9% after suspending operations at about 40 locations.

Analysis

The market is starting to price a classic “bad enough to stay hawkish, not bad enough to force relief” inflation regime. That is usually the worst mix for duration-sensitive equities: rates stay elevated, but growth downgrades lag by a few quarters, so multiples compress before earnings estimates fully reset. The key second-order effect is breadth deterioration — the longer the index grinds lower, the more systematic de-risking hits defensives and quality growth together, which can extend the selloff beyond the obvious rate beneficiaries.

Healthcare looks vulnerable not just because it is rate-sensitive, but because the sector has been trading as a pseudo-bond proxy while reimbursement and wage pressures are still sticky. If the central bank hikes again, the immediate hit is to valuation; the delayed hit is to patient procedure deferrals and channel inventory normalization, which can show up over 1-2 reporting cycles. That makes earnings downgrades more likely to lag price action, creating a window for tactical shorts in the higher-multiple names.

In materials, the move lower in gold exposure is less about the commodity and more about carry and funding pressure: a stronger RBA path tends to support AUD eventually, which can cap local gold margins even if USD bullion is firm. By contrast, energy is the cleanest relative winner because it benefits from both macro inflation persistence and company-specific price realization; the market is underestimating how much higher realized LNG and crude prices can cushion cash flow into the next two quarters. The better read-through is not to buy the index beta, but to rotate toward cash-generative producers with low sustaining capex and avoid companies dependent on domestic demand or refinancing.

The most interesting contrarian angle is that a seventh straight down day could be more of a forced-positioning event than a clean macro verdict. If the RBA ultimately pauses, the rebound could be sharp because shorts in rate-sensitive sectors have grown crowded and the market is already leaning dovish on any single softer inflation print. The risk is asymmetric: near term downside persists for domestic cyclicals, but any policy surprise or global risk-on move could trigger a violent mean reversion.

Key Decisions for Investors

• Short XHJ or a basket of high-duration Australian healthcare names for 1-3 weeks into the RBA decision; use the rate-hike probability as catalyst risk, with a stop if the RBA signals a clear pause path.
• Rotate long AGL/OSH-like energy cash generators and avoid domestic demand proxies over the next 1-2 months; the setup favors firms with pricing power and near-term free cash flow conversion.
• Pair trade long NEM / short CSL over the next 2-4 weeks: gold equities have commodity support but better operating leverage than healthcare if real yields stay sticky; healthcare still has multiple compression risk.
• Buy near-dated ASX index downside protection or short ASX futures into the decision window; the streak and crowded de-risking raise the probability of a fast downdraft if yields reprice higher.
• For a contrarian trade, consider a small tactical long in beaten-up quality defensives only after the RBA event risk clears; the reward is a sharp squeeze if policymakers pause, but keep sizing modest given macro headwinds.